Denali Therapeutics Inc (OQ:DNLI)

Business Focus: Bio Therapeutic Drugs

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for DNLI within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET May 27th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Apr 1/20 Mar 30/20 Krognes Steve E. Direct Ownership Common Stock S - Open market or private sale -1,428 $19.48
Apr 1/20 Mar 30/20 Schuth Alexander O. Direct Ownership Common Stock S - Open market or private sale -1,427 $19.49
Apr 1/20 Mar 30/20 Ho Carole Direct Ownership Common Stock S - Open market or private sale -1,428 $19.48
Apr 1/20 Mar 30/20 Watts Ryan J. Direct Ownership Common Stock S - Open market or private sale -4,807 $19.48
Feb 28/20 Feb 26/20 Bratton Douglas K Indirect Ownership Common Stock S - Open market or private sale -3,894,764 $20.25
Feb 12/20 Feb 10/20 Schuth Alexander O. Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 136,000  
Feb 12/20 Feb 10/20 Schuth Alexander O. Direct Ownership Restricted Stock Units A - Grant, award or other under Rule 16b-3(d) 29,143  
Feb 12/20 Feb 10/20 Krognes Steve E. Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 136,000  
Feb 12/20 Feb 10/20 Krognes Steve E. Direct Ownership Restricted Stock Units A - Grant, award or other under Rule 16b-3(d) 29,143  
Feb 12/20 Feb 10/20 Watts Ryan J. Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 367,675  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for DNLI within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET May 27th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Apr 1/20 Mar 30/20 Krognes Steve E. Direct Ownership Common Stock S - Open market or private sale -1,428 $19.48
Apr 1/20 Mar 30/20 Schuth Alexander O. Direct Ownership Common Stock S - Open market or private sale -1,427 $19.49
Apr 1/20 Mar 30/20 Ho Carole Direct Ownership Common Stock S - Open market or private sale -1,428 $19.48
Apr 1/20 Mar 30/20 Watts Ryan J. Direct Ownership Common Stock S - Open market or private sale -4,807 $19.48
Apr 1/20 Feb 7/20 Krognes Steve E. Direct Ownership Restricted Stock Units M - Exercise or conversion exempt under rule 16b-3 -4,250  
Apr 1/20 Feb 7/20 Krognes Steve E. Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 4,250  
Apr 1/20 Feb 7/20 Schuth Alexander O. Direct Ownership Restricted Stock Units M - Exercise or conversion exempt under rule 16b-3 -4,250  
Apr 1/20 Feb 7/20 Schuth Alexander O. Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 4,250  
Apr 1/20 Feb 7/20 Ho Carole Direct Ownership Restricted Stock Units M - Exercise or conversion exempt under rule 16b-3 -4,250  
Apr 1/20 Feb 7/20 Ho Carole Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 4,250  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $DNLI